Literature DB >> 6123358

Interactions among the effects of normorphine, calcium and magnesium on transmitter release in the mouse vas deferens.

J D Milner, R A North, L V Vitek.   

Abstract

1 Excitatory junction potentials (e. j. ps) were recorded with intracellular electrodes from smooth muscle cells of the mouse vas deferens. 2 The dependence of the e.j.p. amplitude on the extracellular calcium ion concentration was determined in the absence or presence of normorphine (50 nM-1 microM) or magnesium (1.2-4.8 mM). 3 The interaction between normorphine and calcium was non-competitive beyond a dose-ratio of 1.5, whereas the interaction between magnesium and calcium was competitive up to the highest dose-ratio investigated (1.9). 4 It is suggested that inhibition by normorphine occurs at least partly by a mechanism different from that of magnesium.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6123358      PMCID: PMC2068746          DOI: 10.1111/j.1476-5381.1982.tb09189.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  The action of calcium on the electrical properties of squid axons.

Authors:  B FRANKENHAEUSER; A L HODGKIN
Journal:  J Physiol       Date:  1957-07-11       Impact factor: 5.182

2.  The nature of the antagonism between calcium and magnesium ions at the neuromuscular junction.

Authors:  D H JENKINSON
Journal:  J Physiol       Date:  1957-10-30       Impact factor: 5.182

3.  A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens.

Authors:  G Henderson; J Hughes; H W Kosterlitz
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

4.  An electrophysiological analysis of the effect of Ca ions on neuromuscular transmission in the mouse vas deferens.

Authors:  M R Bennett; T Florin
Journal:  Br J Pharmacol       Date:  1975-09       Impact factor: 8.739

5.  Calcium reverses the inhibitory action of morphine on neuroeffector transmission in the mouse vas deferens.

Authors:  P Illes; W Zieglgänsberger; A Herz
Journal:  Brain Res       Date:  1980-06-09       Impact factor: 3.252

6.  On the calcium receptor that mediates depolarization-secretion coupling at cholinergic motor nerve terminals.

Authors:  E M Silinsky
Journal:  Br J Pharmacol       Date:  1981-06       Impact factor: 8.739

7.  Inhibition of neuroeffector transmission by morphine in the vas deferens of naive and morphine-treated mice.

Authors:  P Illes; R Schulz
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

8.  An electrophysiological analysis of the effects of morphine on the calcium dependence of neuromuscular transmission in the mouse vas deferens.

Authors:  M R Bennett; N A Lavidis
Journal:  Br J Pharmacol       Date:  1980-06       Impact factor: 8.739

9.  The effect of chronic morphine treatment of excitatory junction potentials in the mouse vas deferens.

Authors:  R A North; L V Vitek
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

10.  Intracellular magnesium does not antagonize calcium-dependent acetylcholine secretion.

Authors:  E D Kharasch; A M Mellow; E M Silinsky
Journal:  J Physiol       Date:  1981-05       Impact factor: 5.182

View more
  6 in total

1.  Kinetics of antagonist actions at rat P2X2/3 heteromeric receptors.

Authors:  Valeria Spelta; Lin-Hua Jiang; Annmarie Surprenant; R Alan North
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  The effect of opiates on the terminal nerve impulse and quantal secretion from visualized amphibian nerve terminals.

Authors:  N A Lavidis
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

3.  The dependence of excitatory junction potential amplitude on the external calcium concentration in narcotic tolerant mouse vas deferens.

Authors:  R Einstein; N A Lavidis
Journal:  Br J Pharmacol       Date:  1984-12       Impact factor: 8.739

4.  Effect of morphine on the nerve terminal impulse and transmitter release from sympathetic varicosities innervating the mouse vas deferens.

Authors:  N A Lavidis
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

5.  4-Aminopyridine and low Ca2+ differentiate presynaptic inhibition mediated by neuropeptide Y, baclofen and 2-chloroadenosine in rat hippocampal CA1 in vitro.

Authors:  G J Klapstein; W F Colmers
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

6.  On the opioid receptor subtype inhibiting the evoked release of 3H-noradrenaline from guinea-pig atria in vitro.

Authors:  H Fuder; M Buder; H D Riers; G Rothacher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.